About Carotid Stent
Carotid artery disease refers to the blockage or narrowing of carotid arteries due to plaque formation (Fibrous tissue, cholesterol, and calcium deposits. The carotid arteries are present in the neck and supply blood to the brain. Carotid artery stenting is a minimally invasive surgical procedure used to treat carotid artery disease. The technique involves the insertion of a slender metal-mesh tube (carotid stent) through a small incision. The carotid stent expands inside a carotid artery to increase blood flow in areas blocked by plaque. Globally, 90% of carotid surgeries are performed by vascular surgeons.
Technavio's analysts forecast the global carotid stent market to grow at a CAGR of 13.17% over the period 2014-2019.
Covered in this Report
The report includes the present scenario and the growth prospects of the global carotid stent market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from sales of carotid stents.
Technavio's report, Global Carotid Stent Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global carotid stent market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Abbott Vascular
• Boston Scientific
• Cordis (Johnson & Johnson)
• Medtronic
Other Prominent Vendor
• ev3
• Gore Medical
• InspireMD
• Optimed
• Terumo
Market Driver
• High Proportion of Elderly Population
• For a full, detailed list, view our report
Market Challenge
• Complications of Carotid Artery Stenting
• For a full, detailed list, view our report
Market Trend
• Rise in Number of Clinical Trials
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Carotid Artery Stenosis: An Overview
07.1 Background
07.2 Carotid Artery Stenosis
07.2.1 Risk Factors for Carotid Artery Stenosis
07.2.2 Symptoms of Carotid Artery Stenosis
07.3 Treatment Options for Carotid Artery Stenosis
07.3.1 Treatment Recommendation for Symptomatic Carotid Artery Stenosis
07.3.2 Treatment Recommendation for Asymptomatic Carotid Artery Stenosis
08. Carotid Artery Stenting
09. Global Reimbursement Scenario
09.1 Reimbursement Scenario in US
09.1.1 Medicare Reimbursement Policy
09.1.2 Private Insurance Policy
09.1.3 ICD-9-CM Diagnosis Codes and Payments for Carotid Artery Procedures
09.2 Reimbursement Scenario in Other Major Countries
09.2.1 UK
09.2.2 Germany
09.2.3 Spain
09.2.4 Italy
09.2.5 France
09.2.6 Japan
10. Geographical Segmentation
10.1 Global Carotid Stent Market by Geography 2014-2019
10.2 Carotid Stent Market in Americas
10.2.1 Market Size and Forecast
10.3 Carotid Stent Market in EMEA
10.3.1 Market Size and Forecast
10.4 Carotid Stent Market in APAC
10.4.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Major Vendor Analysis 2014
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Boston Scientific
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Key Products
19.2.4 Key Products in Cardiovascular Segment
19.2.5 Key Products in MedSurg Segment
19.2.6 Key Products in Rhythm Management Segment
19.2.7 Business Segmentation by Revenue 2013
19.2.8 Business Segmentation by Revenue 2012 and 2013
19.2.9 Geographical Segmentation by Revenue 2013
19.2.10 Business Strategy
19.2.11 Recent Developments
19.2.12 SWOT Analysis
19.3 Cordis
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation
19.3.4 Business Strategy
19.3.5 Recent Developments
19.3.6 SWOT Analysis
19.4 Medtronic
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Key Products
19.4.4 Business Segmentation by Revenue 2014
19.4.5 Cardiac and Vascular Group Segmentation by Revenue 2014
19.4.6 Restorative Therapies Group Segmentation by Revenue 2014
19.4.7 Diabetes Group Segmentation by Revenue 2014
19.4.8 Business Segmentation by Revenue 2013 and 2014
19.4.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
19.4.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
19.4.11 Diabetes Group Segmentation by Revenue 2013 and 2014
19.4.12 Geographical Segmentation by Revenue 2014
19.4.13 Business Strategy
19.4.14 Key Developments
19.4.15 SWOT Analysis
20. Other Reports in This Series
List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Carotid Stent Market 2014-2019 ($ millions)
Exhibit 3: Management of Carotid Artery Stenosis
Exhibit 4: Steps in Carotid Artery Stenting
Exhibit 5: Various Access Sites for Stenting
Exhibit 6: Global Carotid Stent Market by Geography 2014
Exhibit 7: Carotid Stent Market in Americas 2014-2019 ($ millions)
Exhibit 8: Carotid Stent Market in EMEA 2014-2019 ($ millions)
Exhibit 9: Carotid Stent Market in APAC 2014-2019 ($ millions)
Exhibit 10: Global Carotid Stent Market by Geography 2014-2019 ($ millions)
Exhibit 11: Global Carotid Stent Market by Geography 2014-2019
Exhibit 12: Major Drivers of Global Carotid Stent Market
Exhibit 13: Percentage of Elderly Aged Above 65 in Different Regions and Countries 2012 and 2050
Exhibit 14: Global Incidence of CAD with Age
Exhibit 15: Major Challenges in Global Carotid Stent Market
Exhibit 16: Major Trends in Global Carotid Stent Market
Exhibit 17: Abbott Laboratories: Key Takeaways
Exhibit 18: Boston Scientific: Key Takeaways
Exhibit 19: Cordis: Key Takeaways
Exhibit 20: Medtronic: Key Takeaways
Exhibit 21: Abbott Laboratories: Business Segmentation
Exhibit 22: Abbott Laboratories: Revenue by Business Segmentation 2012
Exhibit 23: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
Exhibit 24: Abbott Laboratories: Revenue by Geographical Segmentation 2012
Exhibit 25: Boston Scientific: Key Products in Cardiovascular Segment
Exhibit 26: Boston Scientific: Key Products in MedSurg Segment
Exhibit 27: Boston Scientific: Key Products in Rhythm Management Segment
Exhibit 28: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 29: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 30: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 31: Cordis: Business Segmentation 2013
Exhibit 32: Medtronic: Key Products
Exhibit 33: Medtronic: Business Segmentation by Revenue 2014
Exhibit 34: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
Exhibit 35: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
Exhibit 36: Medtronic: Diabetes Group Segmentation by Revenue 2014
Exhibit 37: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 38: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 39: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 40: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 41: Medtronic: Geographical Segmentation by Revenue 2014
